<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03192774</url>
  </required_header>
  <id_info>
    <org_study_id>SK 109 -- 168/11</org_study_id>
    <nct_id>NCT03192774</nct_id>
  </id_info>
  <brief_title>The Prospective Segeberg TAVI Registry</brief_title>
  <acronym>POST-TAVI</acronym>
  <official_title>A Prospective Follow-up Assessment of Transcatheter Aortic Valve Implantation in Bad Segeberg</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Segeberger Kliniken GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Segeberger Kliniken GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single center registry including all patients treated with TAVI at the Heart Center, Bad
      Segeberg, Germany
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective single center registry including all patients treated with transcatheter aortic
      valve implantation (TAVI) at the Heart Center, Bad Segeberg, Germany. Patients undergo a
      routine clinical and echocardiographic follow-up schedule, including a long-term follow-up
      plan beyond 5 years to assess valve durability.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2007</start_date>
  <completion_date type="Anticipated">December 2032</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Cardiovascular and not cardiovascular death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Structural valve deterioration</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Transprosthetic mean pressure gradient ≥40 mmHg and/or ≥20 mmHg rise from baseline OR severe intraprosthetic aortic regurgitation</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcatheter Aortic Valve Implantation</intervention_name>
    <description>Interventional replacement of the aortic valve</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All comers patient population treated with TAVI.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients treated with TAVI

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Gert Richardt, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Heart Center, Segeberger Kliniken</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Abdel-Wahab, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Center, Segeberger Kliniken</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohamed Abdel-Wahab, MD</last_name>
    <email>mohamed.abdel-wahab@segebergerkliniken.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ralph Toelg</last_name>
    <email>ralph.toelg@segebergerkliniken.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Center, Segeberger Kliniken</name>
      <address>
        <city>Bad Segeberg</city>
        <zip>23795</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Abdel-Wahab, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 18, 2017</study_first_submitted>
  <study_first_submitted_qc>June 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2017</study_first_posted>
  <last_update_submitted>July 24, 2019</last_update_submitted>
  <last_update_submitted_qc>July 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

